A study by Weizmann Institute of Science scientists reveals that the malaria parasite sends RNA molecules to the nucleus of immune system cells, disrupting their splicing mechanism and diverting the body's defense response from the true focus of infection.
RNA technology, like that used in COVID-19 vaccines, is now at the forefront of medicine, but some have embraced it long before us. The malaria parasite, an ancient single-celled organism, has been making sophisticated use of RNA tricks for thousands of years, if not longer. In a studyRecently published in the scientific journal Cell reports, Weizmann Institute of Science scientists reveal the surprising RNA strategies of the dangerous parasite that kills hundreds of thousands every year, many of them children. The findings may lead to new drugs for malaria as well as RNA-based medical applications.
More than a decade ago, Prof. Neta Regev-Rotsky Because the malaria parasite Plasmodium falciparum ( Plasmodium falciparum) that invades our red blood cells, communicates with its parasitic friends, who are also inside red blood cells, by secreting tiny vesicles containing DNA segments. However, in addition to these segments, Prof. Regev-Rotsky and her group discovered that the vesicles also contain additional molecular cargo, including various types of RNA.
The researchers hypothesized that if the parasite packs RNA molecules into the vesicles, it must have a good reason for doing so. In the new study, the team wanted to test whether the RNA in the vesicles serves special tasks other than transmitting messages. Since Prof. Regev-Rotsky's lab had previously shown that the nanobubbles penetrate not only red blood cells, but also immune system cells called monocytes, the researchers suspected that this was the parasite's way of disrupting the defense mechanisms of the human body in which it is hosted.
It soon became clear that the parasite was more cunning than they had imagined. The team, led by Dr. Paula Abu Karem – then a doctoral student in Prof. Regev-Rotzky’s lab in the Institute’s Department of Biomolecular Sciences – first discovered that the RNA in the vesicles was not just random RNA segments but messenger RNA (mRNA) molecules, that is, instructions for the production of the parasite’s proteins. Despite this discovery, there was no sign of the parasite proteins that were supposed to be formed from those RNA molecules inside the immune system cells. In other words, the parasite did not seem to harness the protein production system of the monocytes at all. Instead, to the researchers’ surprise, the RNA seemed to penetrate the cell’s holy of holies – the nucleus.
"It was inconceivable. The cell jealously guards its nucleus, as its 'brain' is stored there," recalls Prof. Regev-Rotsky. "To convince ourselves – and others – that the parasite's RNA does indeed penetrate these defense systems, we had to identify it directly within the nucleus."
At first, it seemed like an almost impossible task. The malaria parasite's RNA molecules are found in extremely small quantities that get lost in the bustling nucleus of immune system cells. In addition, the parasite's genome itself is remarkably repetitive and consists largely of just two genetic building blocks, A and T. The minute quantity and repetitiveness required a method sensitive enough to detect a drop of parasite RNA in the sea of human genetic material.
"Sometimes what decides a research project is the student leading it, and this was a clear example of that," says Prof. Regev-Rotsky. "Paula took on the challenge and persevered with it for a year and a half, until she finally succeeded."
Dr. Abu Karem developed a fluorescent sensor that caused tiny red dots to light up inside the nucleus of the immune cell. Each dot represented a single parasitic mRNA molecule that had crossed the nuclear barrier.
Having overcome this challenging hurdle and shown with signs and models that the nucleus had indeed been breached and penetrated, the researchers were able to focus on the central question – what are those RNA molecules doing there in the first place? The researchers discovered that they bind to two key components of the cell's "splicing" mechanism – a crucial quality control step without which RNA molecules would often be destroyed without being translated into protein.
In collaboration with the team of Dr. Zeev Melamed From the Hebrew University of Jerusalem, an expert in splicing and RNA, the researchers were able to uncover the parasitic mechanism that disrupts the splicing process in immune system cells and decipher the parasite's RNA strategy. They showed that inserting the parasitic RNA molecules into the monocyte nuclei disrupts the cells' own RNA processing. The result is chaos – essential RNA molecules that should lead to the production of proteins that will fight the parasite are incorrectly spliced and sent for degradation.
Moreover, the disrupted monocytes send out distress signals that trigger a surge of immune system activation and recruitment of additional immune cells. Thus, while these cells rush to deal with the apparent crisis within the monocytes, the real threat – parasites silently multiplying within the red blood cells – escapes attention.
“It’s a diversionary mechanism,” says Prof. Regev-Rotsky. “It’s like throwing a grenade in one direction so that the guards run to it, while you move to another place.” By confusing immune cells and suppressing entire families of key defense proteins, the parasite buys itself valuable time and can reproduce and spread without interference.
These findings point to a potential new target for developing anti-malaria drugs – preventing parasitic RNA from disrupting the splicing mechanism. In addition, the study may also open new avenues for diagnosing other infectious diseases. Bilharzia parasites, for example, can linger in the intestine for years and cause damage while remaining undetected in routine blood tests. Prof. Regev-Rotsky believes that they, like other parasites, may release vesicles whose RNA signatures in the blood could reveal their presence.
The implications of the research also go beyond dealing with infectious diseases. Vesicles of the type released by parasites are common in the human body and characterize, among other things, various diseases. Searching for their cargo not only in the cell fluid but also in unexpected places such as well-preserved nuclei may increase the chance of intercepting these "packages" and reading their contents. Cancer, for example, uses tricks and strategies that include releasing vesicles that affect nearby healthy tissues. Vesicles are also an active area of research in Parkinson's, ALS and other degenerative diseases of the nervous system. It is possible that in the future, RNA circulating in the blood within vesicles may serve as an early biomarker for these diseases.
Also participating in the study were Ido Kiefer, Shaked Yedid, Dr. Eva Kozla, Nir Zaharoni, Dr. Rinat Nevo, Daniel Alfandari, Halina Otsh, Abel Cruz Camacho and Dr. Ofer Shoshani from the Institute's Department of Biomolecular Sciences; Dr. Tamar Ziv from the Technion; Dr. Yoav Lubelsky and Prof. Igor Olitsky from the Institute's Department of Immunology and Biological Regeneration; Dr. Ron Rotkopf, Dr. Yekaterina Pertovich-Kopitman and Dr. Ziv Porat from the Institute's Department of Life Sciences Research Infrastructures; Dr. Eviatar Weizmann from the Nancy and Stephen Grand Israeli National Center for Personalized Medicine; Moshe Kesen from the Hebrew University of Jerusalem; Dr. Irit Goldian from the Institute's Department of Chemical Research Infrastructures and Prof. Carmit Levy from Tel Aviv University.
More on this subject on Hayadan.com - Science news: